Marlene Debel - Feb 27, 2024 Form 4 Insider Report for METLIFE INC (MET)

Role
EVP & Chief Risk Officer
Signature
/s/ Anna Nazarenko, Authorized Signer
Stock symbol
MET
Transactions as of
Feb 27, 2024
Transactions value $
-$1,120,807
Form type
4
Date filed
2/29/2024, 04:21 PM
Previous filing
Feb 26, 2024
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award +5.97K +6.97% 91.5K Feb 27, 2024 Direct F1
transaction MET Common Stock Award +36K +39.3% 127K Feb 27, 2024 Direct F2
transaction MET Common Stock Tax liability -$1.12M -16.2K -12.72% $69.16 111K Feb 27, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MET Employee Stock Options (right to buy) Award $0 +17.9K $0.00 17.9K Feb 27, 2024 Common Stock 17.9K $69.16 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
F2 Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
F3 Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout.
F4 The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.